title: Response of metastatic renal medullary carcinoma to carboplatinum and Paclitaxel chemotherapy.
authors.affiliation: Department of Internal Medicine, Georgia Health Sciences University, Augusta, GA 30912, USA. venureddy82@gmail.com
authors.forename: Venu gopala reddy
authors.initials: Vg
authors.lastname: Gangireddy
authors.forename: Georgia B
authors.initials: GB
authors.lastname: Liles
authors.forename: Gilberto D
authors.initials: GD
authors.lastname: Sostre
authors.forename: Teresa
authors.initials: T
authors.lastname: Coleman
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000556:secondary; D001932:Brain Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000556:secondary; D016190:Carboplatin / Q000008:administration & dosage; D018276:Carcinoma, Medullary / Q000150:complications / Q000188:drug therapy* / Q000556:secondary; D017809:Fatal Outcome; D006801:Humans; D007680:Kidney Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D008113:Liver Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000556:secondary; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D017239:Paclitaxel / Q000008:administration & dosage; D016032:Randomized Controlled Trials as Topic; D012805:Sickle Cell Trait / Q000150:complications; D016896:Treatment Outcome
chemical_list: D016190:Carboplatin; D017239:Paclitaxel